Skip to content

Engaging Sexual and Gender Minority Cigarette Smokers Into Social Media-based Treatment

Social Media-Based Treatment: Engaging Sexual and Gender Minority Smokers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04461288
Enrollment
121
Registered
2020-07-08
Start date
2020-05-01
Completion date
2022-05-30
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking, Nicotine Dependence, Smoking Cessation, Tobacco Use

Keywords

smoking, social media, LGBT, sexual and gender minority, nicotine replacement therapy, digital interventions

Brief summary

This research study will evaluate the preliminary efficacy of Pride Posts Plus, a social media-based smoking cessation treatment. A pilot randomized trial (N=120) will compare Pride Posts Plus, which includes a gamification element, to Pride Posts (without gamification) and to a usual care treatment. Participants will be adults who smoke, identify as sexual or gender minorities, and use Facebook. The primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be treatment engagement, a quit attempt (y/n), and thoughts about tobacco abstinence at 3 and 6 mos.

Detailed description

Participants (N=136) will be randomized to one of three conditions: (1) Pride Posts, a Facebook-delivered smoking cessation intervention (including daily posts, and weekly live group sessions, tailored to sexual and gender minority (SGM) adults; (2) Pride Posts Plus, the Facebook-delivered smoking cessation intervention plus a gamification element, or (2) a usual care condition which includes referral to smokefree.gov, a federally-developed web-based intervention which includes similar digital treatment elements. All participants will have access to up to six months of nicotine replacement therapy (NRT). Assessments will occur at baseline, 3, and 6 months follow-up. Assessments will include measures on smoking, thoughts about abstinence, and SGM identity experiences. All participants who report no past 7-day smoking will be asked to provide biochemical verification of smoking status using a portable carbon monoxide measurement tool. All intervention and assessment procedures will be conducted digitally.

Interventions

BEHAVIORALSocial media-based education, counseling, and support

This six-month intervention is culturally-tailored to sexual and gender minority cigarette smokers. The intervention is group-based and includes daily posts and weekly live sessions during the initial three months. Posts and group sessions focus on tobacco use education, developing a quit plan, as well as managing stress, negative thinking, social support, exercise, as techniques to support cessation.

OTHERNicotine replacement therapies (NRT)

Participants will have access to up to six months of nicotine patch therapy. Participants will start on either 21, 14, or 7 mg patches based on manufacturers recommendations based on smoking behaviors. In addition to nicotine patch, participants will have access to a choice of 2 mg. nicotine lozenges or nicotine gum as an adjunct to patch treatment. Participants will be encouraged to use up to 5 pieces daily to address situational urges and cravings for a cigarette.

OTHERGamification

Gaming elements designed to encourage participation in the program and behavior change.

Sponsors

Tobacco Related Disease Research Program
CollaboratorOTHER
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Daily smoker * Self-identify as sexual and/or gender minority * Interested in quitting in next 6 months * 6 months of Facebook experience * English-speaking

Exclusion criteria

* Contraindications to nicotine replacement therapy

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Reported 7-day Biochemically Verified Abstinence at 3 Months3 monthsAbstinence is defined by all participants who report no smoking within the last 7 days will use a breathalyzer to measure carbon monoxide levels in the breath to verify smoking abstinence prior to the 3 month assessment.
Number of Participants With Reported 7-day Biochemically Verified Abstinence at 6 Months6 monthsAbstinence is defined by all participants who report no smoking within the last 7 days will use a breathalyzer to measure carbon monoxide levels in the breath to verify smoking abstinence prior to the 6 month assessment.

Secondary

MeasureTime frameDescription
Duration of Active Participation3 to 6 monthsTreatment engagement as measured by duration of active participation in intervention.
Number of Participants Whom Attempted to Quit Tobacco Use During the Course of Treatment3 to 6 monthsParticipants will report intentional quit attempts lasting at least 24 hours since treatment initiation or previous assessment
Frequency of social media posts3 to 6 monthsTreatment engagement as measured by frequency of social media posts
Responses to the Thoughts About Abstinence Questionnaire Over Time3 to 6 monthsThe Thoughts About Abstinence Questionnaire is a 5 item self-report questionnaire that measures: 1) desire to quit smoking, 2) expected success at quitting, 3) expected difficulty of quitting, and 4) confidence in ability to quit on 10-point Likert scales (e.g., 1=no desire to quit/lowest expectation/lowest level of difficulty to 10 = extreme desire to quit/highest expectation of success/highest expected difficulty.
Frequency of participation in live group sessions3 to 6 monthsTreatment engagement as measured by participation in live group sessions

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026